Risk of recurrence in major central nervous system malformations between 1976 and 2005

Prenatal Diagnosis

Volumn 27, Issue 11, 2007, Pages 1028-1032

  Joó, József Gábor ^a,b   Beke, Artúr ^a   Papp, Zoltán ^a   Csaba, Ákos ^a   Rab, Attila ^a   Papp, Csaba ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Central nervous system malformation; Folic acid supplementation; Genetic counselling; Neural tube defect; Patient's history; Risk of recurrence

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; CENTRAL NERVOUS SYSTEM MALFORMATION; CONCEPTION; CONSULTATION; CONTROLLED STUDY; DATA ANALYSIS; DIET SUPPLEMENTATION; ECHOGRAPHY; FEMALE; FETUS; FETUS DEVELOPMENT; HUMAN; INFORMATION PROCESSING; INTRAUTERINE INFECTION; MARITAL THERAPY; MEDICAL DOCUMENTATION; NEURAL TUBE DEFECT; PATHOLOGY; PEDIATRICS; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SPINA BIFIDA;

ABNORMALITIES, MULTIPLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; DATABASES, FACTUAL; FEMALE; GENETIC COUNSELING; HUMANS; MALE; PREGNANCY; RECURRENCE; REPRODUCTIVE HISTORY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 36148973158     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1827     Document Type: Article

References (26)

1. Carter CO, Fraser Roberts JA. 1967. The risk of recurrence after two children with central-nervous-system malformations. Lancet 1: 306-308.
2. Czeizel AE, Revesz JG. 1970. Major malformations of the central nervous system in Hungary. Br J Prev Soc Med 24: 205-222.
3. Czeizel AE, Dudas I. 1992. Prevention of first occurrence of neural tube defects by periconceptional vitamin supplementation. N Eng J Med 327: 1832-1835.
4. Hall JG, Friedman JM, Kenna BA, Popkin J, Jawanda M, Arnold W. 1988. Clinical, genetic and epidemiological factors in neural tube defects. Am J Hum Genet 43: 827-837.
5. Hirsch JF, Hirsch E, Sainte Rose C, Renier D, Pierre-Khan A. 1986. Stenosis of the aqueduct of Sylvius. Etiology and treatment. J Neurosurg Sci 30: 29-39.
6. Holmes LB, Shirley MD, Driscoll G, Atkins L. 1976. Etiologic heterogeneity of neural tube defects. N Eng J Med 294: 365-369.
7. Khoury MJ, Erickson JD, James LM. 1982. Etiologic heterogeneity of neural tube defects. II. Clues from family studies. Am J Hum Genet 34: 980-987.
8. Little J. 2000. Epidemiology of neurodevelopmental disorders in children. Prostaglandins, Leukot Essent Fatty Acids 63: 11-20.
9. Locksmith GJ, Duff P. 1998. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstet Gynecol 91: 1027-1034.
10. MacMahon B, Yen S. 1971. Unrecognised epidemic anencephaly and spina bifida. Lancet 1: 31-33.
11. Milham S Jr. 1962. Increased incidence of anencephalus and spina bifida in siblings of affected cases. Science 138: 593-594.
12. Milunsky A, Canick JA. 2004. Maternal serum screening for neural tube defects and other defects. Genetic Disorders and the Fetus. The Johns Hopkins University Press; Baltimore, Maryland, USA: 719-794.
13. Milunsky A, Jick H, Jick SS. 1989. Multivitamin/folic acid supplementation in the earliest weeks of pregnancy reduces the prevalence of neural tube defects. JAMA 262: 2847.
14. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the UK Medical Research Council Vitamin Study. Lancet 338: 131-135.
15. Német J, Papp Z. 1995. Velocsozáródási rendellenességek. Klinikai Genetika. Golden Book Kiadó; Budapest, Hungary: 496-506.
16. Papp CS, Ádám ZS, Tóth-Pál E, Török O, Váradi V, Papp Z. 1997. Risk of recurrence of craniospinal anomalies. J Matern Fetal Med 6: 53-57.
17. Papp Z, Tóth-Pál E, Papp CS, et al. 1995. Impact of prenatal mid-trimester screening on the prevalence of fetal structural anomalies: a prospective epidemiological study. Ultrasound Obstet Gynecol 6: 320-326.
18. Record RG, McKeown T. 1950. Congenital malformations of the central nervous system. III. Risk of malformation in sibs of malformed individuals. Br J Soc Med 4: 217-222.
19. Rosenblatt DS. 2001. Methylenetetrahydrofolate reductase. Clin Invest Med 24: 56-60.
20. Scholl TO, Johnson WG. 2000. Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 71: 129-303.
21. Smith C. 1971. Recurrence risks for multifactorial inheritance. Am J Hum Genet 23: 578-588.
22. Szabó I, Papp Z. 1995. Egyéb craniospinalis rendellenességek. Klinikai Genetika. Golden Book Kiadó; Budapest, Hungary: 515-522.
23. Szeifert GY. 1995. Hydrocephalus. Clinical Genetics. Golden Book Kiadó; Budapest, Hungary: 507-514.
24. van der Put NMJ, Steegers-Theunissen RPM, Frosst P. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1074.
25. Wilcken B, Bamforth F, Li Z. 2003. Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofalte reductase (HTHFR): findings over 7000 newborns from 16 areas world wide. J Med Genet 40: 619-625.
26. Windham GC, Edmonds LD. 1982. Current trend sin the incidence of neural tube defects. Pediatrics 70: 333-337.